CUV100
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: CUV-100 is an advanced dual-action research peptide formulation combining high-purity GHK-Cu (Copper Tripeptide-1, 50mg) and KPV (Lysine-Proline-Valine, 50mg) in an exact 1:1 ratio (100mg total lyophilized material per vial).
How it works: CUV-100 achieves synergistic tissue remodeling and cytoprotection through complementary biochemical cascades: GHK-Cu upregulates pro-collagen I/III synthesis, elastin expression, and stimulates decorin and proteoglycan production while normalizing matrix metalloproteinases (MMPs). Concurrently, KPV acts as a potent tripeptide anti-inflammatory agent via the PepT1 transporter, directly blocking NF-κB nuclear translocation and suppressing pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) without steroidal side effects.
Why researchers study it: Investigated for accelerated dermal and soft-tissue wound repair, severe inflammatory tissue model resolution, extracellular matrix (ECM) reorganization, anti-fibrotic remodeling, and post-procedural tissue healing.
Compound & Molecular Specifications
Certificate of Analysis StandardsFrequently Stacked with GHK-Cu (Copper Tripeptide-1)
Clinically verified combinations activating complementary physiological pathways without receptor competition.
BPC-157 (Pentadecapeptide)
BPC-157 rapidly generates fresh capillary networks (angiogenesis) to deliver oxygen and amino acids to damaged tissue, while GHK-Cu signals fibroblasts to synthesize new type I/III collagen and elastin while inhibiting TGF-beta scar formation.
